Difference in the Prognostic Significance of N-Terminal Pro-B-Type Natriuretic Peptide between Cardioembolic and Noncardioembolic Ischemic Strokes

Table 2

Univariate and multivariate predictors of mortality and functional outcome in the total patient group; odds ratio (95% confidence interval).

Variables	Mortality		Functional outcome
	Univariate	Multivariate	Univariate	Multivariate
Age	1.045 (1.016–1.074)		0.948 (0.931–0.966)
Female gender	2.163 (1.118–4.185)		0.368 (0.237–0.570)
Ischemic heart disease	2.273 (1.153–4.482)
Current smoking			2.836 (1.642–4.899)
Heavy alcohol use			2.843 (1.441–5.612)
LV systolic dysfunction	4.486 (2.048–9.823)	3.818 (1.436–10.151)	0.359 (0.189–0.682)
Cardioembolic source	2.740 (1.340–5.600)
NT-proBNP	16.323 (4.960–53.717)		0.299 (0.190–0.469)
Creatinine	1.408 (1.153–1.720)	1.566 (1.118–2.193)
NIHSS at admission	1.160 (1.114–1.208)	1.135 (1.078–1.195)	0.799 (0.764–0.836)	0.791 (0.742–0.844)

LV: left ventricular; NT-proBNP: N-terminal pro-B-type natriuretic peptide; NIHSS: National Institutes of Health Stroke Scale.